6
Oct
2026

S.A.L.F SpA Laboratorio Farmacologico

Exhibitor at CPHI Milan 2026 stand 16H21, Finished Dosage & Formulation
About Us

S.A.L.F. S.p.A. was founded in Italy in 1921. Main activity:  production of drugs and medical devices (under MDR regulation). Product range: parenteral solutions, injectable solutions, irrigation and rinsing solutions, surgical markers, blood treatment solutions, continuous renal replacement therapy solutions (CRRT), non-sterile concentrated hemodialysis solutions, solutions for organ preservation and perfusion. The finished products can be in different containers: glass ampoules and vials, plastic/glass bottles and PVC-free bags. 

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Italy
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    100 - 249
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 16H21, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • METOCLOPRAMIDE S.A.L.F. 10mg/2ml

    Product METOCLOPRAMIDE S.A.L.F. 10mg/2ml

    La metoclopramide stimola e coordina la motilità del tratto superiore dell’apparato gastroenterico, senza modificare la secrezione gastrica, pancreatica e biliare.Il suo meccanismo d’azione è complesso, essendo il farmaco antagonista competitivo dei recettori D1 e D2 (dopamina) e dei recettori 5-HT3 (s...
  • DOPAMINE S.A.L.F.

    Product DOPAMINE S.A.L.F.

    Dopamine acts as an agonist on specific dopamine receptors and on alpha and beta adrenergic receptors. It decreases peripheral resistance and causes mesenteric and renal vasodilation. It increases renal blood flow, glomerular filtration and urinary flow. ...
  • SERVATOR B SALF

    Product SERVATOR B SALF


    The solution is intended for perfusion and

    hypothermic preservation of kidney, liver and

    pancreas.

    The solution kept bewween at 2° and 6° C (36°

    -43° F) is used to spray the isolated organ

    immediately before or immedi...
  • FUROSEMIDE S.A.L.F. 250mg/25ml solution for infusion or 20mg/2ml solution for injection

    Product FUROSEMIDE S.A.L.F. 250mg/25ml solution for infusion or 20mg/2ml solution for injection

    Pharmacotherapeutic group: Diuretics with a

    major diuretic action.

    Furosemide, a synthesis saluretic agent, causes

    an increase in water and sodium elimination,

    even in cases in which the glomerular filtration

    is very limited. qq...
  • BLU PATENT V 2.5% S.A.L.F. (medical device)

    Product BLU PATENT V 2.5% S.A.L.F. (medical device)


    Patent Blue V is a vital dye suitable for the marking

    of the sentinel lymph node in breast cancer

    and the intraoperative research of the sentinel

    lymph node in patients with colon cancer. It is

    also used in preoperative lymphoscintigraph...

S.A.L.F SpA Resources (1)